-
公开(公告)号:US10266532B2
公开(公告)日:2019-04-23
申请号:US15829243
申请日:2017-12-01
申请人: AbbVie Inc.
发明人: Eric C. Breinlinger , Phil B. Cox , Justin D. Dietrich , Kristine E. Frank , Michael M. Friedman , Huan-Qui Li , Kenton L. Longenecker , Augustine T. Osuma , Ann Marie Rowley , Anil Vasudevan , Noel S. Wilson , Jerome Daanen , Stevan Djuric , Amanda W. Dombrowski , Arthur Gomtsyan , Robert Schmidt
IPC分类号: C07D521/00 , C07D471/04 , C07D471/14 , C07D487/04 , C07D498/04 , C07D498/14 , C07D498/18 , C07D498/20 , C07D498/22 , C07D519/00 , C07D471/18 , C07D491/147 , C07D491/22
摘要: The invention provides tricyclic heterocyclic compounds, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the invention may be useful for treating immunological and oncological conditions.
-
公开(公告)号:US20160304517A1
公开(公告)日:2016-10-20
申请号:US15130362
申请日:2016-04-15
申请人: AbbVie Inc.
发明人: Eric C. Breinlinger , Phil B. Cox , Jerome Daanen , Justin Dietrich , Stevan Djuric , Amanda W. Dombrowski , Kristine E. Frank , Michael M. Friedman , Arthur Gomtsyan , Huan-Qui Li , Kenton Longenecker , Augustine Osuma , Ann Marie Rowley , Robert Schmidt , Anil Vasudevan , Noel Wilson
IPC分类号: C07D471/04 , C07D491/147 , C07D491/22 , C07D498/04 , C07D471/18 , C07D471/14 , C07D498/22 , C07D498/14 , C07D498/20 , C07D487/04 , C07D519/00
CPC分类号: C07D471/04 , C07D471/14 , C07D471/18 , C07D487/04 , C07D491/147 , C07D491/22 , C07D498/04 , C07D498/14 , C07D498/18 , C07D498/20 , C07D498/22 , C07D519/00
摘要: The invention provides tricyclic heterocyclic compounds, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the invention may be useful for treating immunological and oncological conditions.
摘要翻译: 本发明提供三环杂环化合物,药学上可接受的盐,前药,生物活性代谢物,立体异构体和异构体,其中变量在本文中定义。 本发明的化合物可用于治疗免疫学和肿瘤学病症。
-